The International Transporter Consortium: A Collaborative Group of Scientists From Academia, Industry, and the FDA

被引：56

作者：

Huang, S-M ^{[2
]}

Zhang, L. ^{[2
]}

Giacomini, K. M. ^{[1
]}

机构：

[1] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA

[2] US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷 / 01期

关键词：

DRUG-DRUG INTERACTIONS; EFFLUX TRANSPORTERS; KIDNEY; IMPACT; LIVER; OATP;

D O I：

10.1038/clpt.2009.236

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The US Food and Drug Administration-led Critical Path Initiative, launched in 2004, has resulted in an array of activities focused on the sciences that support the development of human medical products.(1) These activities include the development of new scientific tools, such as in vitro testing, qualified biomarkers of drug safety, and innovative new methods in study design and data analysis.(2) As a result of the Critical Path Initiative and enormous advances in the field of membrane transporters, the International Transporter Consortium was formed.

引用

页码：32 / 36

页数：5

共 15 条

[1] Medical product development and regulatory science for the 21st century: The critical path vision and its impact on health care [J].

Buckman, S. ;

Huang, S-M ;

Murphy, S. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) :141-144

[2] ABC Pumps and Their Role in Active Drug Transport [J].

Colabufo, Nicola A. ;

Berardi, Francesco ;

Contino, Marialessandra ;

Niso, Mauro ;

Perrone, Roberto .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (02) :119-129

[3] Novobiocin Is a Potent Inhibitor for Human Organic Anion Transporters [J].

Duan, Peng ;

You, Guofeng .

DRUG METABOLISM AND DISPOSITION, 2009, 37 (06) :1203-1210

[4] The role of hepatic transporters in drug elimination [J].

Funk, Christoph .

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (04) :363-379

[5]

GIACOMINI KM, 2006, PHARMACOL BASIS THER, P41

[6] Intestinal drug transporter expression and the impact of grapefruit juice in humans [J].

Glaeser, H. ;

Bailey, D. G. ;

Dresser, G. K. ;

Gregor, J. C. ;

Schwarz, U. I. ;

McGrath, J. S. ;

Jolicoeur, E. ;

Lee, W. ;

Leake, B. F. ;

Tirona, R. G. ;

Kim, R. B. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (03) :362-370

[7] Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays [J].

Hegedus, Csilla ;

Szakacs, Gergely ;

Homolya, Laszlo ;

Orban, Tamas I. ;

Telbisz, Agnes ;

Jani, Marton ;

Sarkadi, Balazs .

ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (01) :47-56

[8]

Kindla J, 2009, EXPERT OPIN DRUG MET, V5, P489, DOI [10.1517/17425250902911463 , 10.1517/17425250902911463]

[9] In vitro-in vivo Extrapolation of Transporter-mediated Clearance in the Liver and Kidney [J].

Kusuhara, Hiroyuki ;

Sugiyama, Yuichi .

DRUG METABOLISM AND PHARMACOKINETICS, 2009, 24 (01) :37-52

[10] Drug-drug interactions involving membrane transporters in the human kidney [J].

Li, Meng ;

Anderson, Gail D. ;

Wang, Joanne .

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (04) :505-532

← 1 2 →